Legal & General Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-60,386
| Closed | -$1.22M | – | 3594 |
|
|
2021
Q3 | $1.22M | Buy |
60,386
+44,332
| +276% | +$893K | ﹤0.01% | 2190 |
|
|
2021
Q2 | $599K | Buy |
16,054
+1,658
| +12% | +$61.9K | ﹤0.01% | 2307 |
|
|
2021
Q1 | $369K | Sell |
14,396
-295
| -2% | -$7.56K | ﹤0.01% | 2349 |
|
|
2020
Q4 | $323K | Sell |
14,691
-92
| -0.6% | -$2.02K | ﹤0.01% | 2333 |
|
|
2020
Q3 | $265K | Sell |
14,783
-2,862
| -16% | -$51.3K | ﹤0.01% | 2312 |
|
|
2020
Q2 | $448K | Buy |
17,645
+2,088
| +13% | +$53K | ﹤0.01% | 2198 |
|
|
2020
Q1 | $286K | Sell |
15,557
-2,251
| -13% | -$41.4K | ﹤0.01% | 2202 |
|
|
2019
Q4 | $392K | Buy |
17,808
+4,142
| +30% | +$91.2K | ﹤0.01% | 2268 |
|
|
2019
Q3 | $196K | Buy |
13,666
+4,017
| +42% | +$57.6K | ﹤0.01% | 2353 |
|
|
2019
Q2 | $152K | Hold |
9,649
| – | – | ﹤0.01% | 2424 |
|
|
2019
Q1 | $141K | Buy |
9,649
+463
| +5% | +$6.77K | ﹤0.01% | 2402 |
|
|
2018
Q4 | $98K | Buy |
9,186
+2,561
| +39% | +$27.3K | ﹤0.01% | 2465 |
|
|
2018
Q3 | $101K | Hold |
6,625
| – | – | ﹤0.01% | 2509 |
|
|
2018
Q2 | $81K | Buy |
+6,625
| New | +$81K | ﹤0.01% | 2555 |
|